Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Mar-24 6:23 PM View:  | Fortress Biotech, Inc. 10% Owner | Checkpoint Therapeutics, Inc. (CKPT) | 20-Mar-24 | Grant | 193,905 | -- | -- | 10% 1.9M to 2.1M | |
| 01-Mar-24 8:31 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 28-Feb-24 | Sale | 5,894 | $2.06 | $12,141.60 | (2%) 347.67K to 341.78K | |
| 01-Mar-24 8:31 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 28-Feb-24 | Gift | 9,056 | -- | -- | (3%) 356.73K to 347.67K | |
| 01-Mar-24 8:30 PM View: | Gray William Garrett Chief Financial Officer | Checkpoint Therapeutics, Inc. (CKPT) | 28-Feb-24 | Sale | 2,035 | $2.07 | $4,212.45 | (1%) 147.26K to 145.22K | |
| 02-Feb-24 8:10 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 01-Feb-24 | Gift | 12,950 | -- | -- | (3%) 381.58K to 368.63K | |
| 02-Feb-24 8:15 PM View: | Gray William Garrett Chief Financial Officer | Checkpoint Therapeutics, Inc. (CKPT) | 01-Feb-24 | Sale | 4,115 | $1.95 | $8,024.25 | (3%) 151.37K to 147.26K | |
| 02-Feb-24 8:10 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 01-Feb-24 | Sale | 11,900 | $2.01 | $23,919.00 | (3%) 368.63K to 356.73K | |
| 03-Jan-24 4:28 PM View: | Fortress Biotech, Inc. 10% Owner | Checkpoint Therapeutics, Inc. (CKPT) | 29-Dec-23 | Grant | 158,134 | -- | -- | 9% 1.74M to 1.9M | |
| 26-Sep-23 4:16 PM View: | Fortress Biotech, Inc. 10% Owner | Checkpoint Therapeutics, Inc. (CKPT) | 25-Sep-23 | Grant | 80,906 | -- | -- | 5% 1.66M to 1.74M | |
| 02-Feb-24 10:00 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 16-Aug-23 | Gift | 12,510 | -- | -- | (3%) 394.09K to 381.58K | |
| 03-Jul-23 1:15 PM View: | Fortress Biotech, Inc. 10% Owner | Checkpoint Therapeutics, Inc. (CKPT) | 30-Jun-23 | Grant | 81,406 | -- | -- | 5% 1.58M to 1.66M | |
| 15-Jun-23 8:00 PM View: | Rosenwald Lindsay A Md Director | Checkpoint Therapeutics, Inc. (CKPT) | 13-Jun-23 | Grant | 17,483 | -- | -- | 54% 32.64K to 50.12K | |
| 15-Jun-23 8:00 PM View: | Boilen Scott Director | Checkpoint Therapeutics, Inc. (CKPT) | 13-Jun-23 | Grant | 17,483 | -- | -- | 88% 19.86K to 37.34K | |
| 15-Jun-23 8:01 PM View: | Salzman Barry M Director | Checkpoint Therapeutics, Inc. (CKPT) | 13-Jun-23 | Grant | 17,483 | -- | -- | 99% 17.64K to 35.12K | |
| 15-Jun-23 8:00 PM View: | Bechon Christian Director | Checkpoint Therapeutics, Inc. (CKPT) | 13-Jun-23 | Grant | 17,483 | -- | -- | 117% 14.99K to 32.48K | |
| 15-Jun-23 8:01 PM View: | Weiss Michael S Director | Checkpoint Therapeutics, Inc. (CKPT) | 13-Jun-23 | Grant Duplicate | 17,483 | -- | -- | 138% 12.64K to 30.12K | |
| 15-Jun-23 8:00 PM View: | Herskowitz Neil Director | Checkpoint Therapeutics, Inc. (CKPT) | 13-Jun-23 | Grant | 17,483 | -- | -- | 99% 17.64K to 35.12K | |
| 04-Apr-23 4:06 PM View: | Fortress Biotech, Inc. 10% Owner | Checkpoint Therapeutics, Inc. (CKPT) | 04-Apr-23 | Grant | 42,500 | -- | -- | 3% 1.54M to 1.58M | |
| 04-Apr-23 8:30 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 31-Mar-23 | Grant | 250,000 | -- | -- | 174% 144.09K to 394.09K | |
| 04-Apr-23 4:06 PM View: | Fortress Biotech, Inc. 10% Owner | Checkpoint Therapeutics, Inc. (CKPT) | 31-Mar-23 | Grant | 35,714 | -- | -- | 2% 1.5M to 1.54M | |
| 04-Apr-23 8:30 PM View: | Gray William Garrett Chief Financial Officer | Checkpoint Therapeutics, Inc. (CKPT) | 31-Mar-23 | Grant | 100,000 | -- | -- | 195% 51.37K to 151.37K | |
| 03-Mar-23 10:00 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 02-Mar-23 | Sale | 5,483 | $5.00 | $27,415.00 | (4%) 149.57K to 144.09K | |
| 03-Mar-23 10:00 PM View: | Gray William Garrett Chief Financial Officer | Checkpoint Therapeutics, Inc. (CKPT) | 02-Mar-23 | Sale | 3,591 | $5.00 | $17,955.00 | (7%) 54.97K to 51.37K | |
| 03-Mar-23 10:00 PM View: | Gray William Garrett Chief Financial Officer | Checkpoint Therapeutics, Inc. (CKPT) | 27-Feb-23 | Grant | 7,500 | -- | -- | 15% 49.38K to 56.88K | |
| 03-Mar-23 10:00 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 27-Feb-23 | Grant | 15,000 | -- | -- | 11% 140.12K to 155.12K | |
| 03-Mar-23 10:00 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 27-Feb-23 | Sale | 5,548 | $4.65 | $25,798.20 | (4%) 155.12K to 149.57K | |
| 03-Mar-23 10:00 PM View: | Gray William Garrett Chief Financial Officer | Checkpoint Therapeutics, Inc. (CKPT) | 27-Feb-23 | Sale | 1,914 | $4.66 | $8,919.24 | (3%) 56.88K to 54.97K | |
| 02-Feb-24 10:00 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 24-Feb-23 | Gift | 42,000 | -- | -- | (10%) 423.58K to 381.58K | |
| 03-Feb-23 8:00 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 01-Feb-23 | Private Sale | 10,261 | $4.77 | $48,945.00 | (5%) 192.38K to 182.12K | |
| 03-Feb-23 8:00 PM View: | Gray William Garrett Chief Financial Officer | Checkpoint Therapeutics, Inc. (CKPT) | 01-Feb-23 | Private Sale | 3,154 | $4.79 | $15,107.70 | (6%) 52.53K to 49.38K | |
| 12-Jan-23 8:05 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 10-Jan-23 | Private Sale | 3,817 | $6.75 | $25,760.90 | (2%) 196.2K to 192.38K | |
| 12-Jan-23 8:05 PM View: | Gray William Garrett Chief Financial Officer | Checkpoint Therapeutics, Inc. (CKPT) | 10-Jan-23 | Private Sale | 1,858 | $6.75 | $12,539.60 | (3%) 54.39K to 52.53K | |
| 06-Jan-23 5:57 PM View: | Fortress Biotech, Inc. 10% Owner | Checkpoint Therapeutics, Inc. (CKPT) | 05-Jan-23 | Grant | 368,907 | -- | -- | 33% 1.13M to 1.5M | |
| 12-Jan-23 10:00 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 26-Sep-22 | Gift | 60,000 | -- | -- | (23%) 256.2K to 196.2K | |
| 01-Jul-22 9:30 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 23-Jun-22 | Sale | 15,000 | $1.11 | $16,650.00 | (< 1%) 2.58M to 2.56M | |
| 01-Jul-22 9:30 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 22-Jun-22 | Sale | 12,000 | $1.09 | $13,080.00 | (< 1%) 2.59M to 2.58M | |
| 01-Jul-22 9:30 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 21-Jun-22 | Sale | 21,000 | $1.09 | $22,890.00 | (< 1%) 2.61M to 2.59M | |
| 01-Jul-22 9:30 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 17-Jun-22 | Sale | 228,000 | $1.09 | $248,520.00 | (8%) 2.84M to 2.61M | |
| 24-Jun-22 9:55 PM View: | Bechon Christian Director | Checkpoint Therapeutics, Inc. (CKPT) | 16-Jun-22 | Grant | 47,619 | -- | -- | 47% 102.33K to 149.95K | |
| 24-Jun-22 9:53 PM View: | Weiss Michael S Director | Checkpoint Therapeutics, Inc. (CKPT) | 16-Jun-22 | Grant Duplicate | 47,619 | -- | -- | 60% 78.78K to 126.4K | |
| 24-Jun-22 9:54 PM View: | Herskowitz Neil Director | Checkpoint Therapeutics, Inc. (CKPT) | 16-Jun-22 | Grant | 47,619 | -- | -- | 37% 128.78K to 176.4K | |
| 24-Jun-22 9:54 PM View: | Rosenwald Lindsay A Md Director | Checkpoint Therapeutics, Inc. (CKPT) | 16-Jun-22 | Grant | 47,619 | -- | -- | 17% 278.78K to 326.4K | |
| 24-Jun-22 9:54 PM View: | Boilen Scott Director | Checkpoint Therapeutics, Inc. (CKPT) | 16-Jun-22 | Grant | 47,619 | -- | -- | 32% 151.0K to 198.62K | |
| 24-Jun-22 9:53 PM View: | Salzman Barry M Director | Checkpoint Therapeutics, Inc. (CKPT) | 16-Jun-22 | Grant | 47,619 | -- | -- | 37% 128.78K to 176.4K | |
| 22-Apr-22 8:31 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 13-Apr-22 | Sale | 21,258 | $1.51 | $32,099.60 | (< 1%) 2.86M to 2.84M | |
| 22-Apr-22 8:31 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 05-Apr-22 | Sale | 14,030 | $1.77 | $24,833.10 | (< 1%) 2.87M to 2.86M | |
| 22-Apr-22 8:31 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 04-Apr-22 | Sale | 86,353 | $1.79 | $154,572.00 | (3%) 2.96M to 2.87M | |
| 11-Mar-22 7:30 PM View: | Gray William Garrett Chief Financial Officer | Checkpoint Therapeutics, Inc. (CKPT) | 10-Mar-22 | Sale | 38,197 | $1.89 | $72,306.90 | (7%) 582.11K to 543.91K | |
| 22-Apr-22 8:31 PM View: | Oliviero James F III CEO, President and Director Director | Checkpoint Therapeutics, Inc. (CKPT) | 24-Feb-22 | Payment of Exercise | 117,657 | $1.85 | $217,665.00 | (4%) 3.08M to 2.96M | |
| 02-Feb-22 7:01 PM View: | Gray William Garrett Chief Financial Officer | Checkpoint Therapeutics, Inc. (CKPT) | 01-Feb-22 | Sale | 37,063 | $2.51 | $92,954.00 | (3%) 1.24M to 1.2M |
